Study shows new second line therapy for metastatic colorectal cancer is effective and safe
A randomised trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic colorectal cancer, researchers report at the ESMO Asia 2017 Congress.
Nov 20, 2017
0
1